Literature DB >> 20036217

Isoform distinct time-, dose-, and castration-dependent alterations in flavin-containing monooxygenase expression in mouse liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.

Rachel M Novick1, Chad M Vezina, Adnan A Elfarra.   

Abstract

Flavin-containing monooxygenase (FMO) expression in male mouse liver is altered after 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure or castration. Because TCDD is slowly eliminated from the body, we examined hepatic Fmo mRNA alterations for up to 32 days following 10 or 64 microg/kg TCDD exposure by oral gavage in male C57BL/6J mice. Fmo2 mRNA was significantly induced at 1, 4, and 8 days whereas Fmo3 mRNA was also induced at 32 days relative to controls. Fmo3 mRNA levels exhibited a dose-dependent increase at 4, 8, and 32 days after exposure; Fmo1, Fmo4, and Fmo5 mRNA did not exhibit clear trends. Because castration alone also increased Fmo2, Fmo3, and Fmo4 mRNA we examined the combined effects of castration and TCDD treatment on FMO expression. A greater than additive effect was observed with Fmo2 and Fmo3 mRNA expression. Fmo2 mRNA exhibited a 3-5-fold increase after castration or 10 microg/kg TCDD exposure by oral gavage, whereas an approximately 20-fold increase was observed between the sham-castrated control and castrated TCDD-treated mice. Similarly, treatment with 10 microg/kg TCDD alone increased Fmo3 mRNA 130- and 180-fold in the sham-castrated and castrated mice compared to their controls respectively, whereas, Fmo3 mRNA increased approximately 1900-fold between the sham control and castrated TCDD-treated mice. An increase in hepatic Fmo3 protein in TCDD-treated mice was observed by immunoblotting and assaying methionine S-oxidase activity. Collectively, these results provide evidence for isoform distinct time-, dose-, and castration-dependent effects of TCDD on FMO expression and suggest cross-talk between TCDD and testosterone signal transduction pathways. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036217      PMCID: PMC2834820          DOI: 10.1016/j.bcp.2009.12.020

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  54 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.

Authors:  S Katchamart; D M Stresser; S S Dehal; D Kupfer; D E Williams
Journal:  Drug Metab Dispos       Date:  2000-08       Impact factor: 3.922

Review 3.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.

Authors:  Alvaro Puga; Ci Ma; Jennifer L Marlowe
Journal:  Biochem Pharmacol       Date:  2008-09-05       Impact factor: 5.858

4.  Repression of activated aryl hydrocarbon receptor-induced transcriptional activation by 5alpha-dihydrotestosterone in human prostate cancer LNCaP and human breast cancer T47D cells.

Authors:  Noriko Sanada; Yuka Gotoh; Rumiko Shimazawa; Carolyn M Klinge; Ryoichi Kizu
Journal:  J Pharmacol Sci       Date:  2009-03-07       Impact factor: 3.337

5.  Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver.

Authors:  Trine Celius; Steven Roblin; Patricia A Harper; Jason Matthews; Paul C Boutros; Raimo Pohjanvirta; Allan B Okey
Journal:  Drug Metab Dispos       Date:  2008-09-02       Impact factor: 3.922

6.  Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.

Authors:  Jun Zhang; Madhusudana R Chaluvadi; Rob Reddy; Meike S Motika; Terrilyn A Richardson; John R Cashman; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2008-12-16       Impact factor: 3.922

7.  Expression and characterization of functional dog flavin-containing monooxygenase 3.

Authors:  Andrew J Lickteig; Rochelle Riley; Roger J Melton; Beverly A Reitz; H David Fischer; Jeffrey C Stevens
Journal:  Drug Metab Dispos       Date:  2009-07-27       Impact factor: 3.922

Review 8.  AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions.

Authors:  Fumiaki Ohtake; Yoshiaki Fujii-Kuriyama; Shigeaki Kato
Journal:  Biochem Pharmacol       Date:  2008-09-16       Impact factor: 5.858

9.  Purification and characterization of flavin-containing monooxygenase isoform 3 from rat kidney microsomes.

Authors:  Rachel M Novick; Adnan A Elfarra
Journal:  Drug Metab Dispos       Date:  2008-09-05       Impact factor: 3.922

10.  Differential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomes.

Authors:  Rachel M Novick; Ann M Mitzey; Mark S Brownfield; Adnan A Elfarra
Journal:  J Pharmacol Exp Ther       Date:  2009-03-23       Impact factor: 4.030

View more
  5 in total

Review 1.  Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes.

Authors:  Ryan Rossner; Matt Kaeberlein; Scott F Leiser
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

2.  Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver.

Authors:  Trine Celius; Andrea Pansoy; Jason Matthews; Allan B Okey; Marilyn C Henderson; Sharon K Krueger; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-04       Impact factor: 4.219

3.  Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors.

Authors:  Michael C Petriello; Jessie B Hoffman; Manjula Sunkara; Banrida Wahlang; Jordan T Perkins; Andrew J Morris; Bernhard Hennig
Journal:  J Nutr Biochem       Date:  2016-04-01       Impact factor: 6.048

Review 4.  Role of reactive metabolites in the circulation in extrahepatic toxicity.

Authors:  Roy M Irving; Adnan A Elfarra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-06-11       Impact factor: 4.481

5.  Androgen receptor function links human sexual dimorphism to DNA methylation.

Authors:  Ole Ammerpohl; Susanne Bens; Mahesh Appari; Ralf Werner; Bernhard Korn; Stenvert L S Drop; Frans Verheijen; Yvonne van der Zwan; Trevor Bunch; Ieuan Hughes; Martine Cools; Felix G Riepe; Olaf Hiort; Reiner Siebert; Paul-Martin Holterhus
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.